Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterial Fatty Acid Synthase I enzyme complex is central to lipid metabolism in *M. tuberculosis*, producing long-chain fatty acid precursors vital for building its distinctive cell envelope. Its structural uniqueness among prokaryotes—resembling eukaryotic systems—and its essential role make it both biologically significant and pharmacologically attractive as a drug target against tuberculosis infections.
Inhibition of fatty acid synthesis, disruption of cell wall biosynthesis, inhibition of lipid homeostasis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial Fatty Acid Synthase I Enzyme Complex.